We understand the complexities of navigating the jurisdictional differences in core markets. We offer expert European patent advice to help you and your clients realise your IP strategy. We also strongly believe in future-proofing drafts to ensure multijurisdictional protection is not only achievable, but fully aligned with the commercial strategy. By keeping a finger on the pulse of fast-paced legal developments, we are perfectly positioned to help you navigate European IP challenges and opportunities.
European patent strategy
Europe remains a core market for pharmaceutical companies. As highly experienced European patent attorneys we provide tailored drafting and prosecution strategies aligned with your client’s commercial objectives. Our expertise enables us to recommend approaches for expediting prosecution, minimising expenses, or securing meaningful and robust protection against potential infringements. We excel at navigating the evolving landscape of pharmaceutical IP case law and can guide your clients through recent developments in second medical use, antibodies, polymorphs, and cell therapy patenting. Additionally, we offer guidance on managing post-published data, description modifications, and establishing proper basis for claim amendments within the European framework.
European regulatory environment
Patent protection typically forms just one element of your client’s comprehensive market strategy in Europe. We provide insights on the broader regulatory landscape, including EU clinical trial disclosure requirements, Brexit implications, data and market exclusivity periods, and how these mechanisms interact with patent systems throughout Europe to maximise protection and commercial advantage.
EPO oppositions and appeals
A granted European patent can be challenged centrally at the EPO, in every designated state at once, but only within nine months of grant. Where your clients need to clear a competitor’s European patent from their path to market, or to defend their own, we act for them in EPO oppositions and appeals, working alongside you as their lead counsel. We assess quickly whether an opposition is likely to succeed, and build the prior art, priority, sufficiency and added matter arguments. When your clients’ own patents are opposed, we prepare auxiliary requests that protect the commercially important claims, and we represent them before the Boards of Appeal. We also coordinate the European proceedings with challenges in the US and other markets, so that the arguments, evidence and amendments in one forum support your clients’ position in the others.
Fractional IP counsel
Why fractional IP counsel for your clients? When your clients need senior IP leadership in Europe, our fractional IP counsel model can place a named senior patent attorney inside their team as an extension of your own service. Our patent directors bring the real-world industry experience that you only get working in-house, and work alongside you as lead counsel rather than competing with you. Our own AI tools, developed by our attorneys specifically for pharma and biotech IP, let us turn European office actions around quickly and in depth, with the case law and the habits of the EPO built in, while our attorneys make the judgement calls. With our European team behind them, they provide a continuity that a lone consultant cannot, with a global strategic approach that fits the strategy you have set.